Why biology is catalyzing breakthroughs in women's health

Investments targeting the women's health gap could boost the global economy by $1 trillion annually by 2040, according to a recent McKinsey report.

Women's health research is lacking because until 1993, women were largely excluded from clinical trials, leaving significant gaps in understanding diseases affecting women.

The prevalence of pregnancy complications like preeclampsia has doubled in the last 15 years, with current prenatal care models insufficient in predicting and managing risks.

A lack of understanding about ovarian aging and its unique impact on women limits innovative treatments and diagnostics needed for women's health.

Read at Fast Company